The relationship between depressive symptoms and initial quality of life and function in head and neck cancer

✍ Scribed by Jason Y.K. Chan; Lannah L. Lua; Heather H. Starmer; Daniel Q. Sun; Elizabeth S. Rosenblatt; Christine G. Gourin

• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 113 KB
• Volume: 121
• Category: Article
• ISSN: 0023-852X
• DOI: 10.1002/lary.21788

✦ Synopsis

Abstract

Objectives:

To determine the incidence of depression in head and neck cancer (HNCA) patients and the effect of depression on baseline head‐ and neck‐specific measures of quality of life and function.

Study Design:

Prospective cohort analysis.

Methods:

A total of 255 patients were prospectively evaluated using the Beck Depression Inventory Fast‐Screen (BDI‐FS) survey, University of Washington Quality of Life (UW QOL), Voice Handicap Index (VHI), and MD Anderson Dysphagia Inventory (MDADI) questionnaires. Patients with a preexisting diagnosis of depression were excluded.

Results:

Complete data were available for 77 patients with HNCA and 53 controls. Depressive symptoms were identified in 9% of controls and 19% of HNCA patients, and were significantly associated with a HNCA diagnosis (OR = 4.1, P = .044). Among patients with HNCA, depression was significantly more common in black patients (OR = 15.8, P = .017). A significant negative correlation was found between BDI‐FS score and UW global QOL score (r = −0.4, P = .0019). Depression was significantly associated with poorer UW global QOL (β = −22.46, P = .0004), recreation (β = −13.77, P = .037), speech (β = −24.05, P = .004), and MDADI functional (β = −17.31, P = .009), physical (β = −14.99, P = .032), and emotional (β = −11.60, P = .049) domain scores but not with other UW QOL or VHI domains, after controlling for all other variables.

Conclusions:

Patients with HNCA have a high incidence of depressive symptoms at diagnosis, which is significantly higher in black patients, and is associated with poorer QOL and MDADI scores. Pretreatment depression may serve as a marker for patients with increased risk of swallowing impairment and reduced QOL who would benefit from targeted intervention.